Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Ex Vivo Lentiviral Hematopoietic Stem Cell (HSC) Gene Therapy May Represent a Curative Therapy for the Life-Threatening Inborn Error of Immunity Severe Combined Immunodeficiency Due to Adenosine Deaminase (ADA) Deficiency (ADA-SCID)

Blood (2024) 144 (Supplement 1): 1051.

https://doi.org/10.1182/blood-2024-202543

Published: 2024

Journal Articles

HLH: Time to Transplant; A 10-Year UK Retrospective Cohort Study

Andrei Pobischan, Alyce Hayes, Catriona Lewis, Asima Chaudhary, Anupama Rao, Kimberly Gilmour, Jayashree Motwani, Ben Carpenter, Galina Jigoulina, Zohreh Nademi, Srividhya Senthil, Majid Madni, Sushil Gunaseelan, Beki James, Salah Ali

Blood (2024) 144 (Supplement 1): 3915.

https://doi.org/10.1182/blood-2024-210712

Published: 2024

Journal Articles

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL

Blood (2024) 143 (2): 118–123.

https://doi.org/10.1182/blood.2023020621

Published: 2024

Includes: Supplemental data

Journal Articles

A Single Centre Cohort Study of Monitoring B Cell Populations in the Bone Marrow and Peripheral Blood Post Tisagenlecleucel Therapy of Relapsed/Refractory Acute Lymphoblastic Leukaemia

Blood (2023) 142 (Supplement 1): 3508.

https://doi.org/10.1182/blood-2023-182730

Published: 2023

Journal Articles

Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL

Blood (2022) 140 (Supplement 1): 10352–10354.

https://doi.org/10.1182/blood-2022-164879

Published: 2022

Journal Articles

Tvt CAR7: Phase 1 Clinical Trial of Base-Edited "Universal” CAR7 T Cells for Paediatric Relapsed/Refractory T-ALL

Blood (2022) 140 (Supplement 1): 4579–4580.

https://doi.org/10.1182/blood-2022-169114

Published: 2022

Journal Articles

COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation

Blood (2021) 138 (Supplement 1): 1788.

https://doi.org/10.1182/blood-2021-146515

Published: 2021

Journal Articles

TT52CAR19: Phase 1 Trial of CRISPR/Cas9 Edited Allogeneic CAR19 T Cells for Paediatric Relapsed/Refractory B-ALL

Giorgio Ottaviano, Christos Georgiadis, Farhatullah Syed, Soragia Athina Gkazi, Hong Zhan, Annie Etuk, Jan Chu, Danielle Pinner, Sarah Inglott, Kimberly Gilmour, Stuart Adams, Susanne Kricke, Natalia Izotova, Dariusz Ladon, Agnieszka Kubat, Paul Veys, Ajay Vora, Kanchan Rao, Waseem Qasim

Blood (2021) 138 (Supplement 1): 4838.

https://doi.org/10.1182/blood-2021-152426

Published: 2021

Journal Articles

Bipotent Lymphoid Progenitors Independently Maintain Long-Term Genetically Engineered T and NK Cell Production in Humans

Natalia Izotova, Christine Rivat, Cristina Baricordi, PhD, Elena Blanco-Alvarez, Danilo Pellin, Eleanor Watt, Soragia Athina Gkazi, PhD, Stuart Adams, PhD, Kimberly Gilmour, Jinhua Xu Bayford, Claire Booth, MBBS, PhD MSc, Bobby H Gaspar, MBBS, PhD BS, Adrian J. Thrasher, MBBS, PhD FMedSci, Luca Biasco, PhD

Blood (2020) 136 (Supplement 1): 50.

https://doi.org/10.1182/blood-2020-137001

Published: 2020

Journal Articles

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Blood (2019) 134 (Supplement_1): 225.

https://doi.org/10.1182/blood-2019-125009

Published: 2019

Journal Articles

Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center

Giuliana Giardino, Nesrine Radwan, Patra Koletsi, Deborah M. Morrogh, Stuart Adams, Winnie Ip, Austen Worth, Alison Jones, Imke Meyer-Parsonson, H. Bobby Gaspar, Kimberly Gilmour, E. Graham Davies, Fani Ladomenou

Blood (2019) 133 (24): 2586–2596.

https://doi.org/10.1182/blood.2018885244

Published: 2019

Journal Articles

Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

Blood (2018) 132 (19): 2088–2096.

https://doi.org/10.1182/blood-2018-01-827485

Published: 2018

Includes: Supplemental data

Journal Articles

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

Blood (2017) 130 (Supplement 1): 3564.

https://doi.org/10.1182/blood.V130.Suppl_1.3564.3564

Published: 2017

Journal Articles

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult

Blood (2017) 130 (11): 1327–1335.

https://doi.org/10.1182/blood-2017-04-777136

Published: 2017

Includes: Supplemental data

Journal Articles

Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells

Prashant Hiwarkar, Waseem Qasim, Ida Ricciardelli, Kimberly Gilmour, Sergio Quezada, Aurore Saudemont, Persis Amrolia, Paul Veys

Blood (2015) 126 (26): 2882–2891.

https://doi.org/10.1182/blood-2015-06-654780

Published: 2015

Includes: Supplemental data

Journal Articles

First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL

Waseem Qasim, MBBS PhD, Persis Jal Amrolia, Sujith Samarasinghe, MD PhD, Sara Ghorashian, MD PhD FRCPath, Hong Zhan, PhD, Sian Stafford, PhD, Katie Butler, PhD, Gul Ahsan, Kimberly Gilmour, Stuart Adams, PhD, Danielle Pinner, Robert Chiesa, Steve Chatters, PhD, Sue Swift, PhD, Nicholas Goulden, MD PhD, Karl Peggs, MBBChir, MRCP, FRCPath, Adrian J Thrasher, MD PhD, Paul Veys, Martin Pule, PhD

Blood (2015) 126 (23): 2046.

https://doi.org/10.1182/blood.V126.23.2046.2046

Published: 2015

Journal Articles

Immunodeficiency and severe susceptibility to bacterial infection associated with a loss-of-function homozygous mutation of MKL1

Julien Record, Dessislava Malinova, Helen L. Zenner, Vincent Plagnol, Karolin Nowak, Farhatullah Syed, Gerben Bouma, James Curtis, Kimberly Gilmour, Catherine Cale, Scott Hackett, Guillaume Charras, Dale Moulding, Sergey Nejentsev, Adrian J. Thrasher, Siobhan O. Burns

Blood (2015) 126 (13): 1527–1535.

https://doi.org/10.1182/blood-2014-12-611012

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

Rapid Expansion of Naive CD4+ Cord Blood Lymphocytes Restores Adaptive Immunity within 2 Months After Unrelated Cord Blood Transplantation

Robert Chiesa, Prashant Hiwarkar, Kanchan Rao, Waseem Qasim, Kimberly Gilmour, Nicholas Goulden, Persis J Amrolia, Paul Veys

Blood (2010) 116 (21): 2337.

https://doi.org/10.1182/blood.V116.21.2337.2337

Published: 2010

Journal Articles

Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency

Carsten Speckmann, Ulrich Pannicke, Elisabeth Wiech, Klaus Schwarz, Paul Fisch, Wilhelm Friedrich, Tim Niehues, Kimberly Gilmour, Karin Buiting, Michael Schlesier, Hermann Eibel, Jan Rohr, Andrea Superti-Furga, Ute Groß-Wieltsch, Stephan Ehl

Blood (2008) 112 (10): 4090–4097.

https://doi.org/10.1182/blood-2008-04-153361

Published: 2008

Journal Articles

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

Nichola Cooper, Kanchan Rao, Kimberly Gilmour, Lema Hadad, Stuart Adams, Cathy Cale, Graham Davies, David Webb, Paul Veys, Persis Amrolia

Blood (2006) 107 (3): 1233–1236.

https://doi.org/10.1182/blood-2005-05-1819

Published: 2006

NARROW

Ex Vivo Lentiviral Hematopoietic Stem Cell (HSC) Gene Therapy May Represent a Curative Therapy for the Life-Threatening Inborn Error of Immunity Severe Combined Immunodeficiency Due to Adenosine Deaminase (ADA) Deficiency (ADA-SCID)

HLH: Time to Transplant; A 10-Year UK Retrospective Cohort Study

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL

A Single Centre Cohort Study of Monitoring B Cell Populations in the Bone Marrow and Peripheral Blood Post Tisagenlecleucel Therapy of Relapsed/Refractory Acute Lymphoblastic Leukaemia

Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL

Tvt CAR7: Phase 1 Clinical Trial of Base-Edited "Universal” CAR7 T Cells for Paediatric Relapsed/Refractory T-ALL

COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation

TT52CAR19: Phase 1 Trial of CRISPR/Cas9 Edited Allogeneic CAR19 T Cells for Paediatric Relapsed/Refractory B-ALL

Bipotent Lymphoid Progenitors Independently Maintain Long-Term Genetically Engineered T and NK Cell Production in Humans

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center

Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult

Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells

First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL

Immunodeficiency and severe susceptibility to bacterial infection associated with a loss-of-function homozygous mutation of MKL1

Rapid Expansion of Naive CD4+ Cord Blood Lymphocytes Restores Adaptive Immunity within 2 Months After Unrelated Cord Blood Transplantation

Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only